![]() |
市場調査レポート
商品コード
1439432
エラストマーポンプ - 世界市場の考察、競合情勢、市場予測(2030年)Elastomeric Pump - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
エラストマーポンプ - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界のエラストマーポンプの市場規模は、2023年に5億2,300万米ドル、2030年までに7億6,500万米ドルに達し、2024年~2030年の予測期間にCAGRで6.54%の成長が見込まれます。エラストマーポンプ需要の増加は主に、エラストマーポンプの幅広い応用分野、その他のタイプの輸液ポンプと比較した製品設計のシンプルさ、世界中でのエラストマーポンプの入手性などによるものであり、これらが市場を強化し、2024年~2030年の予測期間に市場の成長に寄与する見込みです。
エラストマーポンプの市場力学
エラストマーポンプ市場は、さまざまな理由により製品需要が伸びています。さまざまな用途でエラストマーポンプの使用が増加していることから、予測期間にエラストマーポンプ市場が強化されると見込まれています。
エラストマーポンプは、薬剤の注入に使用される医療機器です。患者が必要とする治療に応じて、抗生物質、化学療法薬、5FU、細胞賦活剤、鎮痛剤、局所麻酔薬などの薬剤があります。
エラストマーポンプは、外来手術センターや在宅医療における化学療法薬の投与に好まれています。また、適切に検査されたエラストマーポンプを使用することで、化学療法薬の無駄を減らすことができます。
エラストマーポンプは、腫瘍や血液の薬剤師および技術者に広く使用されています。また、治療コストを大幅に削減できることから、患者にも広く好まれています。
エラストマーポンプは、術前および術後の疼痛管理などのさまざまな分野で使用されています。術後の初期には、鎮痛剤を調整するために痛みの程度や治療の合併症を毎日評価する必要があるため、投与量を調整できる医療機器へのニーズが高まっています。
このように、さまざまな分野でエラストマーポンプの利用が増加しているため、エラストマーポンプの需要は増加し、エラストマーポンプ市場の成長も増大します。
しかし、ドラッグデリバリーの正確な速度における問題や、異常なドラッグデリバリー速度の検出における失敗が、エラストマーポンプ市場の成長の一定の抑制要因となる可能性があります。
進行中のCOVID-19パンデミックは、がんやその他の疾患の患者の入院はコロナウイルス患者に比べて優先順位が低かったことから、エラストマーポンプ市場に若干の影響を与えています。さらに、パンデミック中、選択的手術は一時的に中止されました。しかし、多くの人々が予防接種を受けたことで、エラストマーポンプ市場は勢いを取り戻しています。
エラストマーポンプ市場のセグメント分析
エラストマーポンプ市場の製品タイプセグメントでは、予測期間(2024年~2030年)に連続速度エラストマー輸液ポンプがエラストマーポンプ市場で高いシェアを占める見込みです。これは、これらのデバイスに関連するさまざまな利点に起因しています。
連続速度エラストマー輸液ポンプの需要は予測期間に増加が見込まれます。これは、エラストマーポンプ技術の進歩によるものです。
例えば、エラストマーポンプは外部チューブを必要としないことから、外来の抗生物質療法に好んで使用されています。
エラストマーポンプはまた、これらのデバイスが容易に冷蔵および冷凍できることから、より長い保存と安定性の仕様を可能にする技術の進歩も有しています。
このように、連続速度エラストマー輸液ポンプの分野における技術の進歩により、連続速度エラストマー輸液ポンプの需要が増加し、このことがエラストマーポンプ市場の成長を促進することになります。
北米はエラストマーポンプ市場全体を独占すると予測されます。
すべての地域の中で、北米が世界のエラストマーポンプ市場で最大のシェアを占めると予測されます。がんや心血管疾患などの慢性疾患の罹患率の増加は、米国の患者への薬剤の投与に用いるエラストマーポンプの北米での需要を増加させ、エラストマーポンプ市場全体の成長の伸びにつながります。
当レポートでは、世界のエラストマーポンプ市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Elastomeric Pumps Market By Product Type (Continuous Rate Elastomeric Infusion Pumps, Variable-Rate Elastomeric Infusion Pumps, Both), By Channel Type (Single Channel, Dual Channel), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to wide application areas and affordability of elastomeric pumps
Global Elastomeric Pumps Market was valued at USD 523 Million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 765 Million by 2030. The increase in demand for Elastomeric Pumps is primarily attributed to the wide application areas of elastomeric pumps, simplicity in product design compared to other types of infusion pumps, affordability of elastomeric pumps across the world are anticipated to bolster the market, thereby contributing to the growth of the Elastomeric Pumps market during the forecast period from 2024-2030.
Elastomeric Pumps Market Dynamics:
The Elastomeric Pumps market is witnessing a growth in product demand owing to various reasons. The increasing use of elastomeric pumps in various applications is anticipated to bolster the market for elastomeric pumps during the forecasted period.
An elastomeric pump is a medical device that is used for the infusion of medication. Depending on the therapy that is required by the patient, the medications comprise antibiotics, chemotherapy, 5FU, cytostatic, analgesics, and local anesthetics.
The elastomeric pumps are continuously been preferred for the administration of chemotherapeutic drugs at ambulatory surgical centers and home care settings. This also increased reduction in the wastage of chemotherapeutic drugs when being used after properly tested elastomeric pumps.
Elastomeric pumps are widely used by oncology and hematology pharmacists and technicians. The devices are also preferred by patients widely owing to a considerable reduction of their treatment costs.
Elastomeric pumps had found their use in various areas of application comprising of both pre and post-operative pain management. In the early days after post-operative surgeries, there is a daily assessment upon the aspect of pain severity and complications of treatment, in order to adjust the analgesic medications, thereby increasing the need for such medical devices that can adjust medication doses.
Thus, due to the increasing utilization of elastomeric pumps in various areas of application, there will be a rising demand for elastomeric pumps, in turn increasing the elastomeric pumps market growth.
However, problems in the accurate rate of drug delivery and failure in the detection of an abnormal rate of drug delivery may be certain limiting factors of the Elastomeric Pumps market growth.
The ongoing Coronavirus disease 2019 (COVID-19) pandemic has slightly impacted the market for elastomeric pumps as hospital admissions for patients suffering from cancers and other disorders were not a priority in comparison to the patients suffering from Coronavirus. Furthermore, elective surgeries were temporarily stopped during the pandemic. However, with masses being vaccinated, the Elastomeric Pumps market has picked momentum.
Elastomeric Pumps Market Segment Analysis:
Elastomeric Pumps Market By Product Type (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps, Both), By Channel Type (Single Channel, Dual Channel), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product Type segment of the Elastomeric Pumps market, the Continuous Rate Elastomeric Infusion Pumps are estimated to hold a higher share in the Elastomeric Pumps market during the forecast period (2024-2030). This can be ascribed to the various advantages that are associated with these devices.
The demand for continuous rate elastomeric infusion pumps is expected to increase during the forecasted period. This is owing to the rising technological advancements of elastomeric pumps.
For instance, elastomeric pumps are preferred in usage for offering outpatient antibiotic therapy, as these devices do not require any external tubing.
Elastomeric pumps also comprise technological advancements that enable longer storage and stability specifications as these devices can be readily refrigerated and frozen.
Thus, owing to the technological advancements in the area of continuous rate elastomeric infusion pumps, there will be an increase in the demand for continuous rate elastomeric infusion pumps, which in turn will drive the Elastomeric Pumps market growth.
North America is expected to dominate the overall Elastomeric Pumps Market:
Among all the regions, North America is expected to account for the largest share in the global Elastomeric Pumps market. Growing incidence of chronic diseases such as cancer, and cardiovascular diseases will increase the demand for elastomeric pumps in North America for administering drugs to patients in the United States, leading to a rise in the overall elastomeric pumps market growth.
For instance, as per the National Cancer Institute 2020, an estimated number of 1,806,590 new cases were diagnosed in the United States and about 606,520 patients will die from the disease.
Also, as per the American Cancer Society, 2020, an estimated number of 1.8 million new cancer cases were diagnosed in the United States.
Also, as per the Centers for Disease Control and Prevention, in the year 2018, 1,708,921 new cases were reported in the United States. As per the same source, for every 100,000 people, 436 new cancer cases were documented and about 149 patients were affected with cancer.
Furthermore, as per the Centers for Disease Control and Prevention, in 2022, about 659,000 people in the United States were affected with heart disorders every year.
Thus, all the above-mentioned factors are anticipated to propel the market for Elastomeric Pumps in the United States.
Elastomeric Pumps Market Key Players:
Some of the key market players operating in the Elastomeric Pumps market include B.Braun Melsungen AG, Nipro Corporation, HEKA s.r.l., Surgika, Baxter, Daiken Medical Co., Ltd, I-Flow Corp., Gamastech Innovative Infusion Systems, Samtronic Industria e Comercio LTDA, Vikymed Italia s.r.l, PAJUNK, Wolf Medical Supply, Ace Medical Co. Ltd., Leventon, S.A.U., Smiths Medical, Assut Europe, Bexen medical, MULTIMEDICAL S.r.l., Ambu Inc., Canox MD. Srl, among others.
Recent Developmental Activities in the Elastomeric Pumps Market:
In March 2022, Fresenius Kabi announced its 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its wireless Agilia® Connect Infusion System which includes the Agilia® Volumetric Pump and the Agilia® Syringe Pump with Vigilant® Software Suite-Vigilant® Master Med technology.
Key Takeaways from the Elastomeric Pumps Market Report Study
Target Audience who can be benefited from this Elastomeric Pumps Market Report Study
Frequently Asked Questions for Elastomeric Pumps Market:
An elastomeric pump is a medical device that is used for the infusion of medication. Depending on the therapy that is required by the patient, the medications comprise antibiotics, chemotherapy, 5FU, cytostatic, analgesics, and local anesthetics.
Global Elastomeric Pumps Market was valued at USD 523 Million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 765 Million by 2030.
The Elastomeric Pumps market is witnessing a positive market growth owing to the wide application areas of elastomeric pumps, simplicity in product design compared to other types of infusion pumps, affordability of elastomeric pumps across the world are anticipated to bolster the market.
Some of the key market players operating in the Elastomeric Pumps market include B.Braun Melsungen AG, Nipro Corporation, HEKA s.r.l., Surgika, Baxter, Daiken Medical Co., Ltd, I-Flow Corp., Gamastech Innovative Infusion Systems, Samtronic Industria e Comercio LTDA, Vikymed Italia s.r.l, PAJUNK, Wolf Medical Supply, Ace Medical Co. Ltd., Leventon, S.A.U., Smiths Medical, Assut Europe, Bexen medical, MULTIMEDICAL S.r.l., Ambu Inc., Canox MD. Srl and others.
North America is expected to hold the highest share in the revenue in the Elastomeric Pumps market during the forecast period. Growing incidence of chronic diseases such as cancer, and cardiovascular diseases will increase the demand for elastomeric pumps in North America for administering drugs to patients in the United States, leading to a rise in the overall elastomeric pumps market growth in this region.